Nephron Research & Santander CIB Form Strategic Alliance for U.S. Growth
Nephron Research and Santander Corporate & Investment Banking (CIB) have joined forces in a strategic alliance. Joshua Raskin and Eric Percher, co-founders of Nephron Research, expressed excitement about the partnership, which aims to better serve their respective clients and unlock new growth opportunities.
This is Santander CIB's third equity research alliance in the United States, following earlier agreements with Telsey Advisory Group LLC and Vertical Research Partners LLC. David Hermer, Head of Santander CIB US, sees this alliance as a significant step in their U.S. growth strategy, expanding the insights and capabilities they offer to clients.
Nephron Research, a leading equity research firm specializing in the healthcare sector, will benefit from Santander's global scale, geographic reach, and financial market capabilities. The firm covers 84 companies and provides health policy coverage. Through this partnership, Nephron Research will broaden its impact, while Santander will strengthen its client offerings with expanded U.S.-based equity research. Joshua Raskin, co-founder and leader of Nephron Research, is actively involved in the firm's operations and strategic partnerships, such as this recent alliance with Santander CIB.
The alliance between Nephron Research and Santander CIB is expected to bring enhanced services to clients on both sides. Nephron Research will gain from Santander's global reach, while Santander will benefit from Nephron's deep sector expertise and established relationships in the healthcare sector.
Read also:
- Trade Disputes Escalate: Trump Imposes Tariffs, India Retaliates; threatened boycott ranges from McDonald's, Coca-Cola to iPhones
- MIH Consortium Chooses BlackBerry for Next-Gen EV Platform
- Aquatech purchases Koch's Direct Lithium Extraction business, merging Li-ProTM DLE technology into the PEARLTM Technology Platform.
- Ukraine's Drone Strikes Cripple Russian Rail, Impacting Military Operations and Economy
